Search Results for: BeiGene
DualityBio, Partner of BioNTech and BeiGene, Files for Hong Kong IPO, Highlighting Several Potential First-in-Class ADCs
2024-08-29
Top 10 U.S. Biomedical & Pharma Clusters of 2024—Part I
2024-08-15
BIO Asia-Taiwan 2024 Conference has Officially Started, With International Leaders in the Industry Gathering Despite the Storm
2024-07-25
BIO Asia-Taiwan Kicks Off with the Latest Cell and Gene Therapy Developments
2024-07-24
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
GeneOnline’s Weekly News Highlights: July 10-14
2023-07-17
Putting Patients First: The Quest to Make Anticancer Cell Therapy Accessible to All
2023-07-04
Jazz Opts Into License Zymeworks’ Solid Tumor Med With $325 Million Payment
2022-12-21
Kite And Arcellx Join Forces for Developing Cell Therapy targeting Multiple Myeloma
2022-12-12
Cell Therapy as a Pillar of Future Therapeutics, an Interview with Alex Huang, Vice President and Head of Cell Therapy at BeiGene
2022-10-05
Taiwan Greenlights BMS, Ono’s Opdivo For Frontline Esophageal Cancer
2022-07-20
Amgen Out-Licenses Two Therapies to Fosun Pharma to Expand Presence in China
2022-06-28
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
2022-06-26
1 2 3 4
Scroll to Top